Rubén
Pío Osés
Catedrático de Universidad
Clínica Universitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (11)
2022
-
Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood
Bioengineering and Translational Medicine, Vol. 7, Núm. 3
-
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer
Cancer Discovery, Vol. 12, Núm. 5, pp. 1356-1377
2021
-
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3
2019
-
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
-
Tmprss4: A novel tumor prognostic indicator for the stratification of stage ia tumors and a liquid biopsy biomarker for nsclc patients
Journal of Clinical Medicine, Vol. 8, Núm. 12
2017
-
Assessment of EGF receptor ligand expression in gastric carcinoma and in lesional skin of paraneoplastic acanthosis nigricans: a case report
Journal of the European Academy of Dermatology and Venereology
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97
2011
2008
-
Identification of Importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens
BMC Molecular Biology, Vol. 9
-
Molecular characterization of small peripheral lung tumors based on the analysis of fine needle aspirates
Histology and Histopathology, Vol. 23, Núm. 1, pp. 33-40
2006
-
Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features
Cancer Epidemiology Biomarkers and Prevention, Vol. 15, Núm. 2, pp. 373-380